0001779994-19-000002.txt : 20190620 0001779994-19-000002.hdr.sgml : 20190620 20190619215309 ACCESSION NUMBER: 0001779994-19-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20190620 DATE AS OF CHANGE: 20190619 EFFECTIVENESS DATE: 20190620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Remiges BioPharma Fund II, LP CENTRAL INDEX KEY: 0001779994 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-342260 FILM NUMBER: 19907372 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-401-2136 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D/A 1 primary_doc.xml X0708 D/A LIVE 0001779994 Remiges BioPharma Fund II, LP ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 617-401-2136 CAYMAN ISLANDS None None Other Cayman Islands exempted limited partnership true 2019 n/a Remiges BioPharma Fund GP II, Inc. One Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director General Partner of the Issuer (the General Partner) Taro Inaba 1-13-9-1809 Kudankita Chiyoda-ku, Tokyo M0 JAPAN 102-0073 Director Director and Chairman of the Board of the General Partner Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 true 0001779994-19-000001 true false true false 0 150000000 0 150000000 false 0 0 0 0 The Issuer is obligated to pay a management fee to the General Partner (or an affiliate thereof). false Remiges BioPharma Fund II, LP /s/ Taro Inaba Taro Inaba Director and Chairman of the Board of the General Partner 2019-06-19